Search Results - "Todd Gillespie"

Refine Results
  1. 1

    Direct Molecular Analysis of Whole-Body Animal Tissue Sections by Imaging MALDI Mass Spectrometry by Khatib-Shahidi, Sheerin, Andersson, Malin, Herman, Jennifer L., Gillespie, Todd A., Caprioli, Richard M.

    Published in Analytical chemistry (Washington) (15-09-2006)
    “…Imaging mass spectrometry (IMS) that utilizes matrix-assisted laser desorption/ionization (MALDI) technology can provide a molecular ex vivo view of resected…”
    Get full text
    Journal Article
  2. 2

    The Disposition of Prasugrel, a Novel Thienopyridine, in Humans by FARID, Nagy A, SMITH, Richard L, GILLESPIE, Todd A, RASH, T. James, BLAIR, Patrick E, KURIHARA, Atsushi, GOLDBERG, Mark J

    Published in Drug metabolism and disposition (01-07-2007)
    “…Prasugrel, a prodrug, is a novel and potent inhibitor of platelet aggregation in vivo. The metabolism of prasugrel and the elimination and pharmacokinetics of…”
    Get full text
    Journal Article
  3. 3

    Mass spectrometry for small molecule pharmaceutical product development: A review by Gillespie, Todd A., Winger, Brian E.

    Published in Mass spectrometry reviews (01-05-2011)
    “…Developing a pharmaceutical product has become increasingly difficult and expensive. With an emphasis on developing project knowledge at an earlier stage in…”
    Get full text
    Journal Article
  4. 4

    A review of nanoelectrospray ionization applications for drug metabolism and pharmacokinetics by Wickremsinhe, Enaksha R, Singh, Gurkeerat, Ackermann, Bradley L, Gillespie, Todd A, Chaudhary, Ajai K

    Published in Current drug metabolism (01-12-2006)
    “…Although traditionally reserved for proteomic analysis, nanoESI has found increased use for small molecule applications related to drug…”
    Get more information
    Journal Article
  5. 5

    Identification of Aliphatic and Aromatic Tertiary N-Oxide Functionalities in Protonated Analytes via Ion/Molecule and Dissociation Reactions in an FT-ICR Mass Spectrometer by Duan, Penggao, Fu, Mingkun, Gillespie, Todd A, Winger, Brian E, Kenttämaa, Hilkka I

    Published in Journal of organic chemistry (06-02-2009)
    “…A mass spectrometric method is presented for the identification of compounds that contain the aliphatic or aromatic N-oxide functional group. This method…”
    Get full text
    Journal Article
  6. 6

    Identification of the Aromatic Tertiary N-Oxide Functionality in Protonated Analytes via Ion/Molecule Reactions in Mass Spectrometers by Duan, Penggao, Gillespie, Todd A, Winger, Brian E, Kenttämaa, Hilkka I

    Published in Journal of organic chemistry (04-07-2008)
    “…A mass spectrometric method is presented for the rapid identification of compounds that contain the aromatic N-oxide functional group. This method utilizes a…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Disposition and Biotransformation of the Antipsychotic Agent Olanzapine in Humans by Kelem Kassahun, Edward Mattiuz, Eldon Nyhart, Jr, Boyd Obermeyer, Todd Gillespie, Anthony Murphy, R. Michael Goodwin, David Tupper, J. Thomas Callaghan, Louis Lemberger

    Published in Drug metabolism and disposition (01-01-1997)
    “…Disposition and biotransformation of the new antipsychotic agent olanzapine (OLZ) were studied in six male healthy volunteers after a single oral dose of 12.5…”
    Get full text
    Journal Article
  10. 10

    The disposition and metabolism of naveglitazar, a peroxisome proliferator-activated receptor α-γ dual, γ-dominant agonist in mice, rats, and monkeys by PING YI, HADDEN, Chad E, ANNES, William F, JACKSON, David A, PETERSON, Barry C, GILLESPIE, Todd A, JOHNSON, Jason T

    Published in Drug metabolism and disposition (2007)
    “…Naveglitazar [LY519818; benzenepropanoic acid, alpha-methoxy-4-[3-(4-phenoxyphenoxy)propoxy], (alpha-S)-] is a nonthiozolidinedione peroxisome…”
    Get full text
    Journal Article
  11. 11

    Three-dimensional quantitative structure activity relationship analyses of substrates for CYP2B6 by Ekins, S, Bravi, G, Ring, B J, Gillespie, T A, Gillespie, J S, Vandenbranden, M, Wrighton, S A, Wikel, J H

    “…To begin to build an understanding of the interactions of CYP2B6 with substrates, two different 3-dimensional quantitative structure activity relationship…”
    Get more information
    Journal Article
  12. 12

    Disposition and Metabolism of Olanzapine in Mice, Dogs, and Rhesus Monkeys by MATTIUZ, E, FRANKLIN, R, GILLESPIE, T, MURPHY, A, BERNSTEIN, J, CHIU, A, HOTTEN, T, KASSAHUN, K

    Published in Drug metabolism and disposition (01-05-1997)
    “…Olanzapine (OLZ) is a novel antipsychotic agent with a high affinity for serotonin (5-HT 2 ), dopamine (D 1 /D 2 /D 4 ), muscarinic (m 1 –m 5 ), adrenergic…”
    Get full text
    Journal Article
  13. 13

    The synthesis of (S)-di-n-propyl-(8-isoxazol-5-yl-1,2,3,4-tetrahydronaphthalen-2-yl)amine hydrochloride and its C-14-labeled isotopomer by Wheeler, William J., O'Bannon, Douglas D., Swanson, Steven, Gillespie, Todd A., Varie, David L.

    “…The partial ergoline LY228729 (1) which was a potent 5HT1A agonist has been studied clinically. Somewhat later, a related analog,…”
    Get full text
    Journal Article
  14. 14

    Analysis of olanzapine in human plasma utilizing reversed-phase high-performance liquid chromatography with electrochemical detection by Catlow, John T., Barton, Richard D., Clements, Matt, Gillespie, Todd A., Goodwin, Michael, Swanson, Steven P.

    “…A sensitive reversed-phase HPLC method for the analysis of olanzapine in human plasma is described. Isolation of olanzapine from plasma was accomplished by…”
    Get full text
    Journal Article
  15. 15

    Identification of the human cytochromes P450 responsible for the in vitro formation of the major oxidative metabolites of the antipsychotic agent olanzapine by Ring, B J, Catlow, J, Lindsay, T J, Gillespie, T, Roskos, L K, Cerimele, B J, Swanson, S P, Hamman, M A, Wrighton, S A

    “…The formation kinetics of 2-hydroxymethyl olanzapine (2-OH olanzapine), 4'-N-oxide olanzapine (N-O olanzapine) and 4'-N-desmethyl olanzapine (NdM olanzapine)…”
    Get more information
    Journal Article
  16. 16

    Olanzapine 10-N-glucuronide : A tertiary N-glucuronide unique to humans by KASSAHUN, K, MATTIUZ, E, FRANKLIN, R, GILLESPIE, T

    Published in Drug metabolism and disposition (01-09-1998)
    “…In humans, a major metabolite of the atypical antipsychotic olanzapine in the plasma and in the urine was found to be an N-glucuronide. Unexpectedly, the…”
    Get full text
    Conference Proceeding Journal Article
  17. 17

    Pergolide: multiple-dose pharmacokinetics in patients with mild to moderate Parkinson disease by Thalamas, Claire, Rajman, Iris, Kulisevsky, Jaime, Lledó, Alberto, Mackie, Alison E, Blin, Olivier, Gillespie, Todd A, Seger, Mary, Rascol, Olivier

    Published in Clinical neuropharmacology (01-05-2005)
    “…The primary objective of this study was to describe the pharmacokinetics of oral pergolide in patients with mild to moderate Parkinson disease using a new…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Olanzapine 10-N-Glucuronide by Kelem Kassahun, Edward Mattiuz, Ronald Franklin, Todd Gillespie

    Published in Drug metabolism and disposition (01-09-1998)
    “…In humans, a major metabolite of the atypical antipsychotic olanzapine in the plasma and in the urine was found to be an N -glucuronide. Unexpectedly, the…”
    Get full text
    Journal Article
  20. 20

    Hot property: geometric homes by Gillespie, Todd

    Published in FT.com (05-04-2019)
    Get full text
    Newspaper Article